Skip to main content
HCA
NYSE Life Sciences

HCA Healthcare to Redeem $2.5B in Near-Term Notes via New Senior Offering

Reported by Wiseek News
Sentiment info
Neutral
Importance info
7
Price
$444.01
Mkt Cap
$99.672B
52W Low
$321.39
52W High
$556.52
Market data snapshot near publication time

Summary

HCA Healthcare announced a proposed offering of senior unsecured notes, with the proceeds earmarked for the conditional redemption of $2.5 billion in near-term debt. Specifically, the company plans to redeem $1.5 billion of 5.250% notes due June 2026 and $1.0 billion of 5.375% notes due September 2026, contingent on the successful completion of the new offering. This announcement provides specific details following an S-3ASR filing and a general Reuters report earlier today regarding a proposed senior notes offering. This proactive debt management move, while a routine capital event for a company of HCA's scale, clarifies the company's strategy to address upcoming maturities. Traders will be watching for the final terms of the new notes to assess the impact on HCA's cost of capital.

At the time of this announcement, HCA was trading at $444.01 on NYSE in the Life Sciences sector, with a market capitalization of approximately $99.7B. The 52-week trading range was $321.39 to $556.52. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HCA - Latest Insights

HCA
May 27, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $392.15
Real-time Price: $380.00 info
Change: -$12.15 (-3%) info
Market Cap: $83.969B info
HCA
Apr 28, 2026, 6:23 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $448.70
Real-time Price: $380.00 info
Change: -$68.70 (-15%) info
Market Cap: $83.969B info
HCA
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $444.01
Real-time Price: $380.00 info
Change: -$64.01 (-14%) info
Market Cap: $83.969B info
HCA
Apr 27, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $448.80
Real-time Price: $380.00 info
Change: -$68.80 (-15%) info
Market Cap: $83.969B info
HCA
Apr 27, 2026, 8:34 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $434.70
Real-time Price: $380.00 info
Change: -$54.70 (-13%) info
Market Cap: $83.969B info
HCA
Apr 24, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $449.99
Real-time Price: $380.00 info
Change: -$69.99 (-16%) info
Market Cap: $83.969B info
HCA
Apr 24, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $437.00
Real-time Price: $380.00 info
Change: -$57.00 (-13%) info
Market Cap: $83.969B info
HCA
Mar 13, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $532.97
Real-time Price: $380.00 info
Change: -$152.97 (-29%) info
Market Cap: $83.969B info
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $502.05
Real-time Price: $380.00 info
Change: -$122.05 (-24%) info
Market Cap: $83.969B info
HCA
Feb 10, 2026, 8:05 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $502.05
Real-time Price: $380.00 info
Change: -$122.05 (-24%) info
Market Cap: $83.969B info